RxDoctor Payments Data

Donald Wilkerson, MD

Vascular Surgery · Baltimore, MDNPI 1922045541

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,567 of the $2,436 with a category attached, or 64.3%. 12 manufacturers reported payments, led by Bard Peripheral Vascular, Inc. at 52.2% of the total. Reporting peaked in 2021 at $1,665 and has fallen 97.4% since, to $43 in 2025. That places this record below the midpoint for vascular surgery clinicians in MD, where the typical reported total is $3,095.

$2,436in general payments, 2019–2025

Across 45 payments — averaging $54.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bard Peripheral Vascular, Inc.$1K
  • Angiodynamics, Inc.$466
  • Abbott$264
  • Johnson & Johnson$121
  • Medtronic$119
  • Terumo Medical Corporation$58
  • plus $137 from 6 others

What the payments were for

  • Speaking & faculty fees$231%
  • Travel & lodging$84635%
  • Food & beverage$1,56764%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,436 in reported general payments places this provider in the 45th percentile of 104 vascular surgery providers in Maryland.

See all vascular surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$3,957,604
Medicare patients
266
Services billed
19,509

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate42$439

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →